Zoltan Bakos

Zoltan Bakos

Auto-generated profile, based on publicly available information

Zoltan Bakos

Department of Cardiology, Kristianstad Hospital , Kristianstad , Sweden

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
ZBZ. Bakos
Z. Bakos
NCN. C. Chatterjee
N. C. Chatterjee
CRC. Reitan
C. Reitan
JSJ. P. Singh
J. P. Singh
RBR. Borgquist
R. Borgquist
Cardiac resynchronization therapy (CRT) is an established therapy for appropriately selected patients with heart failure. Response to CRT has been heterogeneously defined using both clinical and echocardiographic measures, with poor correlation between the two. The study cohort was comprised of 202 CRT-treated patients and CRT response was defined at 6 months post-implant. Echocardiographic response (E+) was defined as a reduction in LVESV ≥ 15%, clinical response as an improvement of ≥ 1 NYHA class (C+), and biomarker response as a ≥ 25% reduction in NT-proBNP(B+). The association of response measures (E+, B+, C+; response score range 0–3) and clinical endpoints at 3 years was assessed in landmarked Cox models. Echo and clinical responders demonstrated greater declines in NT-proBNP than non-responders (median [E+/B+]: -52%, [E+]: -27%, [C+]: -39% and [E-/C-]: -13%; p = 0.01 for trend). Biomarker (HR 0.43 [95% CI: 0.22–0.86], p = 0.02) and clinical (HR 0.40 [0.23–0.70] p = 0.001) response were associated with a significantly reduced risk of the primary endpoint. When integrating each response measure into a composite score, each 1 point increase was associated with a 31% decreased risk for a composite endpoint of mortality, LVAD, transplant and HF hospitalization (HR 0.69 [95% CI: 0.50–0.96], p = 0.03), and a 52% decreased risk of all-cause mortality (HR 0.48 [95% CI: 0.26–0.89], p = 0.02). Serial changes in NT-proBNP are associated with clinical outcomes following CRT implant. Integration of biomarker, clinical, and echocardiographic response may discriminate CRT responders versus non-responders in a clinically meaningful way, and with higher accuracy. The cohort was combined from study NCT01949246 and the study based on local review board approval 2011/550 in Lund, Sweden.

28 March 2014 in EP Europace
Verified
Journal Article
Open access
PDF file
CRChristian Reitan
Christian Reitan
ZBZoltan Bakos
Zoltan Bakos
PPPyotr G Platonov
Pyotr G Platonov
CHCarl-Johan Höijer
Carl-Johan Höijer
JBJohan Brandt
Johan Brandt
RBRasmus Borgquist
Rasmus Borgquist
Cardiac resynchronization therapy (CRT) has a well-documented positive effect on mortality and heart failure morbidity. The aim of this study was to assess the long-term survival and the predictive value of self-assessed functional status on the long-term prognosis of patients treated with CRT-pacemaker (CRT-P). Data were retrospectively collected from medical records of 446 consecutive patients implanted with CRT-P at a large-volume Swedish tertiary care centre. Primary outcome was all-cause mortality, predictive variables were assessed by log-rank test and univariate cox regression. Three hundred and nine patients had reliable information available on early improvement after implantation and were included in the multivariate analyses. The cohort was followed for a median of 79 months and was similar in baseline characteristics compared with major controlled trials. During follow-up 204 patients died, yearly mortality was 11.7%. Early improvement of self-assessed functional status was a strong independent predictor of survival [hazard ratio, HR 0.59, confidence interval (CI) 0.40–0.87, P = 0.007], together with well-known predictors; NYHA III–IV vs I–II (HR 1.66, CI 1.09–2.536, P = 0.018), age (HR 1.05, CI 1.03–1.08, P < 0.001), male gender (HR 2.0, CI 1.11–3.45, P = 0.021), and loop diuretic use (HR 4.41, CI 1.08–18.02). Patients with early improvement of self-assessed functional status had better 2-year and 5-year survival (P < 0.001). Real-life patient characteristics and predictors of outcome compare well with those in published prospective trials. Self-assessed functional status is a strong predictor of long-term survival, which may have implications for a more active follow-up of patients without spontaneous improvement.

1 January 2001 in Acta Veterinaria Hungarica
Verified
Journal Article
Open access
GBG. Bodó
G. Bodó
AKA. D. Kaposi
A. D. Kaposi
LHL. Hangody
L. Hangody
JTJ. Tóth
J. Tóth
ZBZ. Bakos
Z. Bakos
GPG. Péntek
G. Péntek
Six pieces of grafts, 6.5 mm in diameter, 20 mm in length, were taken from each of 170 cadaver hindlimbs, using the cranial surface of the medial femoral trochlea for harvesting. The age of the horses varied between 4 months and 23 years. 30 limbs under the age of 12 years were selected for transplantation. Three of six grafts were transplanted into the medial femoral condyle using different combinations of tunnel depth and dilation. With ageing, a significant decline in transplantability was detected. In general, mosaicplasty cannot be recommended in horses above 11 years. Based on a previous clinical case (Bodo et al., 2000), a good surface alignment was indeed achieved with a combination of graft length drilling and dilation in most cases. However, the occasional entrapment of cartilage debris under the graft prevented perfect alignment in the present cadaver study in 27% of the grafts transplanted in this manner. Since the protrusion of grafts never exceeded 1.5 mm, we conclude that drilling 3–5 mm deeper than graft length with graft length deep dilation can avoid disadvantageous protrusion of the transplanted hyaline cartilage caps, achieving bone decompression at the same time.

2 August 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
DFDaniel Benjamin Fyenbo
Daniel Benjamin Fyenbo
HBHenrik Laurits Bjerre
Henrik Laurits Bjerre
MFMaria Hee Jung Park Frausing
Maria Hee Jung Park Frausing
CSCharlotte Stephansen
Charlotte Stephansen
ASAnders Sommer
Anders Sommer
JNJens Cosedis Nielsen
Jens Cosedis Nielsen
Several studies have evaluated the use of electrically- or imaging-guided left ventricular (LV) lead placement in cardiac resynchronization therapy (CRT) recipients. We aimed to assess evidence for a guided strategy that targets LV lead position to the site of latest LV activation. A systematic review and meta-analysis was performed for randomized controlled trials (RCTs) until March 2023 that evaluated electrically- or imaging-guided LV lead positioning on clinical and echocardiographic outcomes. The primary endpoint was a composite of all-cause mortality and heart failure hospitalization, and secondary endpoints were quality of life, 6-min walk test (6MWT), QRS duration, LV end-systolic volume, and LV ejection fraction. We included eight RCTs that comprised 1323 patients. Six RCTs compared guided strategy (n = 638) to routine (n = 468), and two RCTs compared different guiding strategies head-to-head: electrically- (n = 111) vs. imaging-guided (n = 106). Compared to routine, a guided strategy did not significantly reduce the risk of the primary endpoint after 12–24 (RR 0.83, 95% CI 0.52–1.33) months. A guided strategy was associated with slight improvement in 6MWT distance after 6 months of follow-up of absolute 18 (95% CI 6–30) m between groups, but not in remaining secondary endpoints. None of the secondary endpoints differed between the guided strategies. In this study, a CRT implantation strategy that targets the latest LV activation did not improve survival or reduce heart failure hospitalizations.

10 October 2018 in Acta Radiologica
Verified
Journal Article
Closed access
PDF file
HMHanna Markstad
Hanna Markstad
ZBZoltan Bakos
Zoltan Bakos
EOEllen Ostenfeld
Ellen Ostenfeld
MGMats Geijer
Mats Geijer
MCMarcus Carlsson
Marcus Carlsson
RBRasmus Borgquist
Rasmus Borgquist
Successful cardiac resynchronization therapy (CRT) requires appropriate left ventricular (LV) lead placement on a suitable segment of the free LV wall. Current guidelines suggest targeted lead placement, but the individual anatomy of the cardiac veins is often a limiting factor. To map cardiac veins with multidetector computed tomography (MDCT) and plot the veins in cardiac segments to facilitate successful CRT implantation. Ninety-nine patients were included (mean age = 68 ± 9 years; 26% women; 46% ischemic cardiomyopathy). Contrast-enhanced, ECG-gated, dose-modulated MDCT was used to depict the coronary veins. CT data were reformatted into short-axis view. Veins with diameter ≥1.5 mm and traversing the free LV wall were manually transferred into a 17-segment bulls-eye plot model. In 98 patients, a CT scan with acceptable image quality was obtained. Median radiation dose as dose-length protocol was 231 mGy/cm (interquartile range = 276 mGy/cm). Mean contrast dose, expressed as total iodine load, was 38 ± 8 g. A median of three suitable veins (range = 1–7) covered a mean of 4.4 ± 1.5 relevant LV segments. There was no difference between patients with dilated or ischemic cardiomyopathy in number of veins (2.5 vs. 2.7, P = 0.45) or in number of cardiac segments traversed by suitable veins (4.4 vs. 4.5, P = 0.74). In CRT patients, MDCT can be used for preoperative mapping of the cardiac veins to assess availability of suitable veins in potential target segments for pacemaker-lead placement. Using the 17-segment plot of the left ventricle may improve the clinical usefulness of the data.

1 June 2013 in EP Europace
Verified
Journal Article
Open access
PDF file
DPD. Penela
D. Penela
ABA. Berruezo
A. Berruezo
RER. Evertz
R. Evertz
JFJ. Fernandez-Armenta
J. Fernandez-Armenta
DAD. Andreu
D. Andreu
CCCanadian Heart Rhythm Society Device Committee
Canadian Heart Rhythm Society Device Committee
Introduction: Survival benefit of cardiac resynchronization therapy with a backup defibrillator (CRT-D) over cardiac resynchronization therapy alone (CRT-P) is not clearly proven and both strategies are a class I indication in heart failure (HF) patients. No clear variables to select the appropriate therapy are available. We hypothesized that myocardial scar characterization can predict long term ventricular arrhythmias in these patients.